Constitutively activated mutants of the Ras-related protein TC21/R-Ras2 cause tumorigenic transformation of NIH3T3 cells. However, unlike Ras, TC21 fails to bind to and activate the Raf-1 serine-threonine kinase. Thus, whereas Ras transformation is critically dependent on Raf-1 TC21 activity is promoted by activation of Rafindependent signaling pathways. In the present study, we have further compared the functions of Ras and TC21. First we determined the basis for the inability of TC21 to activate Raf-1. Whereas Ras can interact with the two distinct Ras-binding sequences in NH 2 -terminus of Raf-1, designated RBS1 and Raf-Cys, TC21 could only bind Raf-Cys. Thus, the inability of TC21 to bind to RBS1 may prevent it from promoting the translocation of Raf-1 to the plasma membrane. Second, we found that TC21 is an activator of the JNK and p38, but not ERK, mitogen-activated protein kinase cascades and that TC21 transforming activity was dependent on Rac function. Thus, like Ras, TC21 may activate a Rac/JNK pathway. Third, we determined if TC21 could cause the same biological consequences as Ras in three distinct cell types. Like Ras, activated TC21 caused transformation of RIE-1 rat intestinal epithelial cells and terminal dierentiation of PC12 pheochromocytoma cells. Finally, activated TC21 blocked serum starvation-induced dierentiation of C2 myoblasts, whereas dominant negative TC21 greatly accelerated this dierentiation process. Therefore, TC21 and Ras share indistinguishable biological activities in all cell types that we have evaluated. These results support the importance of Rafindependent pathways in mediating the actions of Ras and TC21.
Introduction
The detection of mutated ras genes in 30% of all human cancers has implicated an important contribution of aberrant Ras function to human carcinogenesis (Barbacid, 1987; Bos, 1989; Clark and Der, 1993) . The three mammalian ras genes encode four highly related proteins (H-Ras, K-Ras4A, K-Ras4B, and N-Ras) that are members of a large superfamily of small GTPases (Boguski and McCormick, 1993) . The Ras superfamily (greater than 70 mammalian members) is comprised of 20 ± 25 kDa proteins that share strong sequence (30 ± 55% amino acid identity) and biochemical (GDP/GTPregulated binary switches) similarities with Ras proteins (Bourne et al., 1990) . Based on sequence identity and function, the members of the Ras superfamily have been divided into distinct branches that include the Ras, Rho, Rab, Ran, Rit/Rin, Rheb, Rad/Gem, and Arf/Arl branches. Members of the Ras subfamily include those with the strongest amino acid identity with Ras proteins (50 ± 55%): R-Ras, TC21/RRas2, M-Ras/R-Ras3 (Matsumoto et al., 1997; Kimmelman et al., 1997) , four Rap proteins, and two Ral proteins .
Despite possessing strong structural and biochemical similarities with Ras proteins, only a limited number of Ras-related proteins have been shown to exhibit transforming potential . Constitutively activated mutants of several Rho family proteins can promote transformation of NIH3T3 cells although they cause a transformed phenotype that is distinct from that caused by oncogenic Ras mutants. Furthermore, it has been shown that Ras transformation is dependent on the function of speci®c Rho family proteins. Although R-Ras exhibits transforming properties in NIH3T3 cells Saez et al., 1994) , R-Ras may regulate cellular processes (apoptosis, integrin-mediated cellular adhesion) distinct from Ras (Wang et al., 1995; Zhang et al., 1996) . To date, only constitutively activated mutants of the TC21/R-Ras2 protein have exhibited the same potent transforming activity as oncogenic Ras. Like oncogenic mutants of Ras, constitutively activated mutants of TC21 also cause transformation of NIH3T3 and Rat-1 rodent ®broblasts and of MCF-10 human mammary epithelial cells (Graham et al., 1994; Chan et al., 1994; Clark et al., 1996) .
Considerable biological, biochemical and genetic evidence implicates the Raf-1 serine/threonine kinase as a key eector of Ras transformation. Activated Ras complexes with and promotes activation of the Raf-1 serine/threonine kinase (Van Aelst et al., 1993; Vojtek et al., 1993; Moodie et al., 1993; Warne et al., 1993; Zhang et al., 1993 ). Activated Raf-1 then activates mitogen activated protein kinase (MAPK) kinases (MEK1 and MEK2), which then activate p42 and p44 MAPKs (also called ERK2 and ERK1, respectively) (Howe et al., 1992; Dent et al., 1992; Kyriakis et al., 1992; Lange-Carter et al., 1993; Zheng and Guan, 1994; Reuter et al., 1995) . Activated ERKs then translocate into the nucleus where they phosphorylate and activate nuclear transcription factors such as Elk-1 (Hill et al., 1993) , resulting in immediate-early gene induction (reviewed by) (Marshall, 1995; Hill and Treisman, 1995) . Kinase-de®cient mutants of Raf-1, MEKs and ERKs can block Ras transformation (Kolch et al., 1991; Cowley et al., 1994; Westwick et al., 1994; Khosravi-Far et al., 1995) . Conversely, constitutively activated mutants of Raf-1 (Stanton Jr et al., 1989; Bonner et al., 1985; Leevers et al., 1994; Stokoe et al., 1994) and MEK (Cowley et al., 1994; Mansour et al., 1994) cause tumorigenic transformation of rodent ®broblasts. These observations demonstrate the key importance of the Raf/MEK/MAPK pathway in mediating Ras function.
Ras causes Raf-1 activation, in part, by interaction with two distinct regions in the NH 2 -terminus of Raf-1, designated Ras-binding site 1 (RBS1) and the cysteinerich domain (Raf-CRD) (Vojtek et al., 1993; Brtva et al., 1995; Hu et al., 1995) . Ras interaction with both RBS1 and Raf-CRD are required for Raf-1 activation, to promote Raf-1 translocation to the plasma membrane, and to initiate subsequent membraneassociated events required for full activation of its kinase activity (Morrison and Cutler Jr, 1997) . The steps required for full activation of Raf-1 are complex and remain to be delineated (Morrison and Cutler Jr, 1997) . Ras is believed to interact with RBS1 through residues within and surrounding the switch I region (Ras residues 30 ± 38), whereas mutations in regions anking switch I and II (Ras residues 59 ± 76) interfere with Ras:CRD interactions and Raf-1 activation (Drugan et al., 1996; Clark et al., 1997a) . Switch I and II correspond to the regions of Ras which dier in conformation between the active, GTP-complexed and inactive, GDP-complexed proteins. Although TC21 and Ras share strong amino acid identity in these two regions, TC21 fails to bind to and activate full length Raf-1 (Graham et al., 1996) . However, it can interact with a truncated Raf-1 protein that lacks the COOH-terminal catalytic domain, but retains portions of the NH 2 -terminal RBS1 and Raf-CRD domains. Why TC21 fails to interact with full length Raf-1 is presently unclear.
Although there is considerable evidence that Raf is a key eector of Ras function, there is growing support for the involvement of multiple eectors in mediating Ras signaling and transformation. First, a spectrum of functionally diverse candidate Ras eectors has been identi®ed. These include guanine nucleotide exchange factors for the Ras-related protein Ral (RalGDS, RGL and RGL2/Rlf) (Kikuchi et al., 1994; Hofer et al., 1994; Spaargaren and Bischo, 1994; Wolthuis et al., 1996; Peterson et al., 1996) , phosphatidylinositol-3-OH kinases (PI3Ks) (Rodriguez-Viciana et al., 1994; Chantry et al., 1997) , the MEKK1 serine-threonine kinase (Russell et al., 1995) , the two Ras GTPase activating proteins (p120 GAP and neuro®bromin) (Bollag and McCormick, 1992) , Rin1 (Han and Colicelli, 1995) and AF6 (Van Aelst et al., 1994; Kuriyama et al., 1996) . Like Raf-1, these functionally diverse proteins show preferential binding to the active GTP-bound form of Ras and this interaction requires an intact Ras core eector domain (amino acids 32 ± 40) (Marshall, 1993) . Second, the determination that eector domain mutants of Ras, which have lost the ability to bind to and activate Raf-1, still retain potent transforming activity demonstrates that Ras interaction with other eectors contributes to Ras transformation (White et al., 1995; Joneson et al., 1996; Khosravi-Far et al., 1996) . Finally, since Ras, but not Raf, causes transformation of RIE-1 and other epithelial cells (Oldham et al., 1996) , it is clear that Ras activation of the Raf/MAPK pathway alone is not sucient for Ras transformation of some cells. Thus, Ras causes transformation by activation of both Raf-dependent and Raf-independent pathways. Whether TC21 utilizes non-Raf eectors that are shared with Ras has not been clearly resolved. However, the ability of constitutively activated TC21 to overcome the loss of endogenous Ras function caused by the Ras(17N) dominant negative protein suggests that there is considerable functional overlap between TC21 and Ras (Hu et al., 1997) .
Activated Ras causes distinct biological activities when expressed in dierent cell types (Barbacid, 1987; Clark and Der, 1993) . Oncogenic Ras causes morphologic and tumorigenic growth transformation of both NIH3T3 ®broblasts and RIE-1 intestinal epithelial cells (Barbacid, 1987; Clark and Der, 1993) . Although Ras activation of Raf is not sucient to cause transformation of RIE-1 cells, Raf activation of ERKs is still necessary for transformation of these epithelial cells (Oldham et al., 1998) . Activated Ras also alters the dierentiation potential of certain cell types. For example, activated Ras causes neurite induction and cessation of growth of PC12 pheochromocytoma cells (Bar-Sagi and Feramisco, 1985; Noda et al., 1985) . Since activated Raf-1 or MEK also causes PC12 cell dierentiation (Wood et al., 1993; Cowley et al., 1994) , it is believed that Ras activation of the Raf/ERK pathway alone is sucient to cause its eects on these cells. Consistent with this possibility, R-Ras (70% similarity with TC21) does not activate Raf (Hu et al., 1997) and does not cause dierentiation of PC12 cells (Rey et al., 1994) . Activated Ras has been shown to block either serum starvation-(C2 skeletal myoblasts) or myoD-(C3H10T1/2 ®broblasts) induced myoblast dierentiation (Olson et al., 1987; Kong et al., 1995) . Since activated Raf also blocks myoD-induced dierentiation, Ras activation of Rafdependent pathways are sucient to alter myoblast dierentiation (Ramocki et al., 1997) . Thus, since TC21 is not an activator of Raf-1 (Graham et al., 1996) , it is not clear whether TC21 would, or would not, cause the same eects as activated Ras in RIE-1, PC12 and C2 cells.
In the present study, we have further compared the signaling and biological activities of TC21 and Ras. We found that the failure of TC21 to activate Raf-1 may be due to an inability to promote Raf-1 translocation to the plasma membrane, that Ras and TC21 both activate a Rac/JNK pathway, and that TC21 and Ras share indistinguishable growth or dierentiation activities in a wide variety of cell types. These results demonstrate that TC21 can promote the same cellular consequences as Ras via Raf-independent pathways and provide further support for the importance of non-Raf eectors in the regulation of Ras and TC21 function.
Results
TC21 can bind to the Raf-1 cysteine-rich domain, but not RBS1, Ras-binding sequences present in the NH 2 -terminus of Raf-1
The Raf-1 serine/threonine kinase contains two autonomously folded Ras-binding domains (Brtva et al., 1995; Hu et al., 1995) and Ras interaction with both appears to be necessary for Ras activation of Raf-1 (Drugan et al., 1996) . The ®rst Ras binding site (RBS1) is contained in Raf-1 residues 50 ± 130, whereas the second Ras-binding site is contained in the Raf-1 cysteine-rich domain (Raf-CRD; residues 139 ± 184). Although activated TC21 is not capable of binding full-length Raf kinases (cRaf-1, A-Raf and B-Raf) when assayed in yeast two-hybrid binding assays, we observed previously that removal of the COOHterminal kinase domain results in an NH 2 -terminal fragment that is capable of binding to TC21 (Graham et al., 1996) . As the Raf-CRD is known to be cryptic in the intact, unstimulated Raf-1 protein, we suspected that the removal of the kinase domain unmasked binding determinants in the Raf-CRD (Clark et al., 1997a) . However, it is also possible that the truncation of Raf-1 results in a conformational change that exposed the Ras-binding determinants of RBS-1. To distinguish between these two possibilities, we assessed the ability of TC21 to bind to the isolated RBS1 and Raf-CRD domains.
To determine whether TC21 could interact with either isolated Ras binding domain of Raf-1, we puri®ed bacterially-expressed GST-TC21(WT), HRas(12V), RBS1 and Raf-CRD. TC21 was removed from the GST-TC21 fusion protein. While we could detect binding between Ras and the two Ras-binding domains of Raf-1 (RBS1 and Raf-CRD), we could detect binding only between TC21 and Raf-CRD, and not with RBS1, as shown by ELISA analyses ( Figure  1a and b). Figure 1a compares the ability of RBS-1 to interact with TC21 or Ras(12V). Ras(12V) was chosen for this assay because it has a reduced rate of GTP hydrolysis while still binding the ®rst Ras-binding site of Raf-1 similarly to wild type (WT) Ras (Drugan et al., 1996) . Whereas RBS-1 clearly bound to Ras(12V)-GTP, TC21 did not.
As the Raf-CRD binds nonprenylated Ras with lower anity than to the isolated RBS-1 (Drugan et al., 1996) , we utilized ELISAs to assess the binding properties of the isolated Raf-CRD independent of RBS-1. To obviate GTP hydrolysis, Ras and TC21 were bound to a slowly hydrolyzable GTP analog, GMPPNP. Moreover, to control for subtle dierences between the binding properties for the Raf-CRD to WT and Ras(12V) (Drugan et al., 1996) , we utilized Ras(WT) for these studies. As shown in Figure 1b , Raf-CRD bound TC21 with a similar ratio over background as did wild type Ras. Thus, the restoration of TC21 binding to Raf-1 following the truncation of the Raf-1 kinase domain may be due, in part, to the exposure of binding determinants in the Raf-CRD.
TC21 can activate the JNK and p38, but not ERK, MAPKs
Although TC21-transformed NIH3T3 cells did not show upregulated Raf kinase activity (Graham et al., 1996) , we observed previously that they do possess upregulated p42 and p44 MAPKs/ERKs (Graham et al., 1994) . Whether ERK upregulation was activated by TC21, via a Raf-independent pathway, or was a secondary consequence of TC21 transformation, was not determined. To evaluate whether TC21 could cause direct activation of ERKs, we utilized transient expression assays using COS-7 cells. We also determined if TC21 could activate the JNK and p38 MAPK cascades.
For analysis of ERK activation, COS-7 cells were cotransfected with expression plasmids encoding either wild type or activated TC21(72L) or Ras(61L), along with an expression plasmid encoding hemagglutinin (HA) epitope-tagged p42 MAPK /ERK2. After 48 h, HA-ERK2 was immunoprecipitated using an anti-HA epitope antibody. This complex was then incubated with [g-32 P]APT and myelin basic protein (MBP), which is an in vitro substrate for activated ERKs. We observed that whereas activated Ras caused strong activation of ERK2 (greater than ninefold), neither TC21(WT) nor TC21(72L) caused any signi®cant activation of ERK2 ( Figure 2 ). These results suggest that TC21 does not cause direct activation of ERKs and the elevated ERKs seen in TC21-transformed cells may be due to secondary events that occur in stablytransformed cells.
In addition to ERKs, oncogenic Ras can also activate the JNK and p38 MAPK cascades, via a Raf-independent pathway(s) that involves the small GTPase Rac (Minden et al., 1994; Olson et al., 1995) . Furthermore, dominant negative SEK1, an upstream activator of JNK and p38, has been shown to block Ras activation of JNKs and transformation (Clark et al., 1997b) . To determine if TC21 could activate these MAPK cascades, we coexpressed activated TC21(72L) with FLAG epitope-tagged versions of JNK or p38. Immunoprecipitated FLAG-JNK or FLAG-p38 were isolated by immunoprecipitation and used for in vitro kinase assays using recombinant c-Jun and ATF-2 as substrates, respectively. We observed that although TC21(WT) was unable to appreciably cause activation of JNK, like activated Ras, activated TC21 did cause strong activation of JNK (fourfold) (Figure 2 ). We also observed that TC21(72L) could activate p38 and this level of activation was comparable to that caused by activated Ras(61L). TC21(WT) also caused a limited (twofold) activation of p38 (Figure 2) . Thus, whereas TC21 does not activate the Raf/ERK cascade, it can activate the Raf-independent JNK and p38 signaling cascades.
Rac is necessary for Ras and TC21 transformation of NIH3T3 cells
Members of the Rho family of small GTPases have been shown to be necessary for Ras transformation and signaling (Qiu et al., 1995a (Qiu et al., ,b, 1997 Khosravi-Far et al., 1995; Prendergast et al., 1995) . In addition to activation of JNKs, Rac has also been implicated in mediating Ras activation of NF-kB (Sulciner et al., TC21 signaling and biological activity SM Graham et al 1996) and stimulation of superoxide production (Irani et al., 1997) . We have found that inhibition of NF-kB or superoxide both block Ras transformation (Clark et al., 1997b; Irani et al., 1997) . We showed previously that TC21 is an activator of NF-kB (Graham et al., 1994) . To determine if Rac function is also required for TC21 transformation we coexpressed activated TC21(72L) together with the Rac1(17N) dominant negative mutant and assayed for a reduction of transforming activity. We observed that whereas coexpression of Rac1(WT) did not block TC21 focusforming activity, coexpression of Rac(17N) caused a 70% reduction of TC21(72L) focus-formation and this level of inhibition was comparable to that seen with activated Ras(61L) (Figure 3 ). This suggests that activation of a Rac-mediated signaling pathway is important for both Ras and TC21 transformation of NIH3T3 cells. Activated TC21 and Ras show indistinguishable biological activity in RIE-1 rat intestinal epithelial and PC12 rat pheochromocytoma cells
We have shown recently that RIE-1 rat intestinal epithelial cells are sensitive to Ras, but not Raf, transforming activity (Oldham et al., 1996) . However, inhibition of ERK activation was sucient to block Ras transformation (Oldham et al., 1998) . Thus, Ras activation of the Raf/ERK pathway is necessary, but not sucient, to cause transformation of RIE-1 cells. Therefore, we anticipated the possibility that activated TC21 may not be able to transform this cell type. To evaluate this possibility, we established RIE-1 cells that stably expressed TC21(72L) and then determined if they acquired any characteristics of growth transformation. We observed that expression of activated TC21 induced potent morphological transformation of RIE-1 cells, comparable to that caused by expression of oncogenic Ras (Figure 4 ). In addition, we observed that RIE-1 cells stably expressing TC21(72L) readily formed colonies in soft agar at a frequency comparable to that of RIE-1 cells expressing activated Ras proteins (data not shown). Thus, TC21 and Ras share comparable abilities to cause transformation of RIE-1 cells.
We next determined if, like oncogenic Ras (Bar-Sagi and Feramisco, 1985; Noda et al., 1985) , activated TC21 could cause terminal dierentiation of PC12 rat pheochromocytoma cells. Since activated Raf or MEK can cause terminal dierentiation of PC12 cells, it is believed that Ras activation of the Raf/ERK pathway alone is sucient to mediate these eects (Wood et al., 1993; Cowley et al., 1994) . Thus, TC21 may not share this biological property with Ras. To address this possibility, we introduced expression plasmids that encoded wild type or activated versions of TC21 or HRas into cultures of PC12 cells, then maintained these One hundred pmoles of Raf-CRD, which have been cleaved from GST, were immobilized to each well of a polystyrene 96-well plate. Following blocking with gelatin and normal sheep serum, the Raf-CRD was exposed to 100 pmoles TC21-GMPPNP fused to GST, GST alone, or Ras(WT)-GMPPNP. The captured protein was labeled with an anti-GST monoclonal or anti-H-Ras monoclonal antibody. Following incubation with anti-mouse IgG-alkaline phosphatase (AP) antibody, the interaction between the Raf-CRD and the protein of interest is detected by a colorimetric change following the addition of an AP substrate, pnitrophenyl phosphate. After 30 min, the optical density is measured at 405 nm with a Biotech microtiter plate reader. All experiments were done at least three times in duplicate cultures in G418-containing growth medium to isolate stably-transfected cells. After approximately one week, cells expressing activated Ras began to show evidence of dierentiation. Ras(61L)-expressing cells displayed neurite outgrowth and stopped dividing, whereas the vector-transfected controls continued to divide and showed no evidence of neurite formation ( Figure 5 ). To our surprise, however, the cells expressing TC21(72L) also showed the same dierentiation response ( Figure  5 ). However, expression of TC21(72L) was not as potent an inducer of dierentiation of PC12 cells as expression of Ras(61L). Whereas greater than 90% of the Ras-transfected cells showed evidence of differentiation within a week, only 60 ± 80% of the cells transfected with TC21(72L) showed evidence of dierentiation. We also observed that TC21(WT)- Figure 2 TC21 activates JNK and p38, but not ERK, MAPKs. COS-7 cells transfected with 1 mg each plasmid DNA encoding epitope-tagged ERK (HA-ERK2), JNK (FLAG-JNK), or p38 (FLAG-p38), in combination with 1 mg of either pCGN-hyg empty vector control, pCGN-H-ras(61L), pCGN-tc21(WT), or pCGN-tc21(72L) were harvested after 18 h of serum starvation. Protein concentration was determined by the BCA protein assay and lysates were standardized for HA-ERK2, FLAG-JNK, or FLAG-p38 levels by Western Blot analysis. To perform the kinase assays, respective lysates were incubated with anti-HA or anti-FLAG antibody and immune complexes were incubated with myelin basic protein (MBP), or GST-cJun or GST-ATF-2 that is complexed to glutathione beads. Samples were run in SDS/PAGE for resolution of the proteins. Relative 32 P incorporated into MBP, c-Jun, or ATF from activated ERK, JNK, or p38, respectively, was quantitated using a Phosphoimager The pZIP-NeoSV(x)1 empty vector (Vector) was used as a negative control. After 48 h, cells were grown in selection growth medium that contained G418 (400 mg per ml) to establish cell lines that stably expressed these mutant proteins Figure 5 TC21 causes dierentiation and inhibits the proliferation of PC12 pheochromocytoma cells. Rat pheochromocytoma cells (PC12) were transfected with 10 mg of pZIP plasmid cDNAs encoding normal or mutant TC21 or Ras proteins [pZIPtc21(WT), -tc21(72L), -ras(WT), or -ras(61L)]. After 48 h, cells were transferred to growth medium that contained G418 (400 mg per ml) to isolate and establish cell lines that stably expressed normal or mutant proteins. When cells began to die, conditioned medium was collected from parental PC12 cells that was then combined with fresh selection medium (1 : 2 ratio), and cells were fed every day for approximately 2 weeks. At this time, the cultures were scored for the percentage of cells that showed neurite induction expressing cells exhibited weak signs of dierentiation, comparable to that caused by Ras(WT). Approximately 20% of PC12 cells stably-expressing wild type Ras or TC21 underwent terminal dierentiation. Thus, like Ras, TC21 can induce terminal dierentiation of PC12 cells.
Like Ras, activated TC21 blocks serum starvationinduced dierentiation of C2 skeletal myoblasts Stable expression of activated Ras in C2 skeletal myoblasts has been shown to cause growth transformation of these cells and to inhibit the ability of these cells to undergo dierentiation when the growth medium is depleted of calf serum (Olson et al., 1987) . Additionally, both activated Ras and Raf blocked MyoD-induced myogenesis when transiently expressed in C3H10T1/2 mouse ®broblasts (Kong et al., 1995; Ramocki et al., 1997) . Thus, Raf-dependent pathways mediate, in part, the ability of oncogenic Ras to block myogenesis. To determine if activated TC21 could also block myogenesis, we established C2 cells that stably expressed wild type or activated mutants of TC21 or H-Ras. Multiple G418-resistant colonies were pooled together after drug selection of the transfected cultures. As seen with activated Ras, C2 cells stably expressing activated TC21 also became morphologically-transformed and showed enhanced growth rates and saturation densities (data not shown). We then induced their dierentiation by serum starvation and the addition of insulin. Under these conditions, the empty-vector transfected C2 cells showed evidence of dierentiation within 5 ± 7 days that was characterized by the cessation of mitotic growth and the formation of myotubes. In contrast, C2 cells stably expressing activated Ras or TC21 were blocked in this differentiation response (Figure 6 ). Neither expression of TC21(WT) nor H-Ras(WT) aected the differentiation potential of C2 cells (data not shown). A comparable ability of activated Ras and TC21 to block MyoDinduced myogenic dierentiation of C3H10T1/2 cells was also seen (data not shown). Thus, activated Ras and TC21 share the ability to impair myogenic dierentiation.
The ability of activated TC21 to impair C2 dierentiation suggested that loss of endogenous TC21 function may accelerate the dierentiation response. To address this possibility, we established C2 cells stably expressing dominant negative mutants of TC21, designated TC21(26A) and TC21(28N) (Graham et al., 1996) . These mutants are analogous to the Ras(15A) and Ras(17N) dominant negative proteins, and antagonize TC21 function by forming nonproductive complexes with guanine nucleotide exchange factors that activate TC21 as well as Ras (e.g., SOS) (Quilliam et al., 1995) . We observed that expression of TC21(26A) or TC21(28N) alone did not have any eect on the dierentiation of C2 cells when they were maintained in growth medium containing 15% fetal calf serum. However, when subjected to serum starvation, C2 cells stably expressing either TC21(26A) or TC21(28N) were dramatically accelerated in their rate of dierentiation. TC21 protein is expressed in skeletal muscle tissue (Graham et al., 1996) . However, since TC21 is activated by Ras GEFs (SOS and RasGRF), the actions of dominant negative TC21 may also be due to inhibition of activation of Ras or other Ras GEF targets, such as M-Ras/R-Ras3.
The ability of TC21 to block C2 myoblast dierentiation argues that Ras-mediated inhibition is also Raf-independent. To address this directly, we determined if a Ras eector domain mutant, Ras(12V, 37G), that is impaired in its ability to activate Raf or PI3K (White et al., 1995; Khosravi-Far et al., 1996; Rodriguez-Viciana et al., 1997) , retained this inhibitory activity. We found that C2 cells stably expressing A B Figure 6 TC21 modulates serum starvation-induced differentiation of C2 skeletal myoblasts. (a) C2-myoblast cells were transfected with 1 mg of pZIP plasmid cDNAs encoding normal or mutant TC21 or Ras proteins [pZIP-tc21(WT), -tc21(72L), -tc21(26A), -tc21(28N), -ras(WT), or -ras(61L)]. After 24 h, cells were grown in selection growth medium that contained G418 (400 mg per ml) to establish cell lines that stably expressed normal or mutant proteins. To induce dierentiation, C2 cells stably expressing either vector control, Ras or TC21 proteins were grown to 70% con¯uency, then fed with DMEM containing 2% horse serum and 10 mg/ml insulin. After approximately 1 week of growth in dierentiation medium, cells expressing the indicated proteins were scored for any acquired dierentiation characteristics. Data shown are the morphological change observed after 3 days of growth in dierentiation medium. (b) Analyses of C2 cells stably transfected with pCDR expression vectors encoding HRas(12V) or H-Ras(12V,37G) by procedures as described in (b) Ras(12V,37G) caused both morphologic transformation and inhibition of serum-starvation induced myoblast dierentiation (Figure 6b ). In contrast, we have failed to observe any inhibition of C2 dierentiation when activated forms of Raf-1 were stably expressed in C2 cells. Thus, neither Ras activation of Raf or PI3K are required for blocking myogenesis.
Discussion
Although constitutively activated mutants of TC21 and Ras cause transformation of NIH3T3 and Rat-1 rodent ®broblasts, only Ras causes activation of the Raf/ERK pathway (Graham et al., 1996) . Since there is considerable evidence that Ras activation of Raf is critical for full transforming activity, the equivalent ability of TC21 to cause transformation without activation of this key Ras eector was unexpected. In the present study, we determined the basis for the failure of TC21 to activate Raf-1, determined if TC21 could activate other MAPK cascades and whether TC21 transformation was dependent on Rac function. We also extended our biological analyses to determine if a failure of TC21 to activate Raf would prevent it from causing other known growth and dierentiation regulating actions induced by oncogenic Ras. We found that the inability of TC21 to bind to or activate Raf-1 is most likely due to its inability to bind to the NH 2 -terminal minimal Ras-binding sequence (RBS1). Transient expression analyses showed that TC21 could activate the JNK and p38, but not ERK, MAPK cascades and that Rac was required for full TC21 transforming activity. Thus, like Ras, TC21 function may also be dependent on a Rac/JNK pathway. Finally, despite its failure to activate Raf, TC21 caused the same biological consequences when expressed in RIE-1, PC12 and C2 cells. Taken together, these results demonstrate that TC21 and Ras share equivalent biological functions and suggest that much of Ras function may also not be dependent on Raf function.
In addition to the minimal Ras-binding sequence (Raf-1 residues 50 ± 130; RBS1), we and others have recently determined that Ras can interact with a second Ras-binding domain in the NH 2 -terminal regulatory domain of Raf-1 (Raf-CRD) (Brtva et al., 1995; . Furthermore, analyses of transformationdefective mutants of Ras showed that Ras transformation required interaction with both RBS1 and Raf-CRD (Drugan et al., 1996) . We have postulated that Ras interaction with RBS1 is important for promoting Raf-1 translocation to the plasma membrane, whereas Ras interaction with Raf-CRD promotes subsequent events required for activation of Raf-1 kinase function. These include the removal on the negative regulatory actions of 14-3-3, which can also interact with the Raf-CRD (Clark et al., 1997a) . Although TC21 shares strong sequence identity with Ras residues involved in its interaction with Raf-1, we found that TC21 failed to interact with and activate full length Raf-1. In this study, we found that TC21 could not interact with RBS1, yet could interact with the normally cryptic Raf-CRD. Thus, the failure of TC21 to activate Raf-1 is most likely due to its inability to promote the translocation of Raf-1 to the plasma membrane. These results also support our proposal that the Raf-CRD is cryptic in the full length protein and that interaction with both RBS1 and Raf-CRD are required for Ras activation of Raf-1.
Although we have reported that TC21-transformed cells show no upregulation of Raf kinase activity, we have observed that these cells, like Ras-transformed cells, do show upregulated ERKs. These results suggest either that TC21 can activate ERKs, via a Rafindependent pathway, or that ERK upregulation may be a secondary event that is triggered by growth transformation of NIH3T3 cells. One possible mechanism may involve TC21 activation of an autocrine growth loop that then causes activation of ERKs. Alternatively, it may re¯ect cross-talk between ERK and other MAPK cascades. For example, it has been reported that activation of the JNK pathway can cause upregulation of ERKs via a Raf-independent mechanism (Frost et al., 1996) . Our demonstration that TC21 can activate the JNK and p38 MAPKs provides support for this second possibility.
Our observations that TC21 can activate JNK, and that Rac is required for full TC21 transforming activity, suggest that TC21 and Ras do share the ability to activate a Rac/JNK pathway. We have shown previously that p120 GAP may serve as an eector for Ras activation of JNKs and that JNK activation is required for full Ras transforming activity (Clark et al., 1997b) . We also found that p120 GAP can stimulate the intrinsic GTP hydrolytic activity of TC21 in vitro, suggesting that p120 GAP can also serve as an eector for TC21. While the precise contribution of Rac to Ras transformation is not fully elucidated, it has been shown that Rac mediates Ras-induced membrane-ruing (Joneson et al., 1996) , activation of JNK (Minden et al., 1994; Olson et al., 1995) , stimulation of NF-kB (Sulciner et al., 1996) and induction of superoxide production (Irani et al., 1997) . Since activation of JNK and NF-kB, as well as superoxide production, have been shown to be important for Ras transformation (Clark et al., 1997b; Finco et al., 1997; Mayo et al., 1997; Irani et al., 1997) , it is likely that Rac will contribute to TC21 transformation by promoting these same cellular events. Whether blocking NF-kB activation in TC21-transformed cells causes the same induction of apoptosis that we have seen with Ras-transformed cells would support this possibility (Mayo et al., 1997) .
Since TC21 fails to activate Raf, whether Ras and TC21 could cause the same cellular consequences in RIE-1 and PC12 cells was not clear. First, we have found that Ras activation of the Raf/ERK pathway is necessary, but not sucient, to cause transformation of RIE-1 cells (Oldham et al., 1996 (Oldham et al., , 1998 . Thus, it is possible that the ability of TC21 to cause upregulation of ERKs via a non-Raf pathway may allow TC21 to transform RIE-1 cells. Second, the ability of activated Raf and MEK to cause terminal dierentiation of PC12 cells argued that Ras-mediated terminal differentiation was caused primarily by activation of Raf (Wood et al., 1993; Cowley et al., 1994) . Again, a possible explanation for these results may be that TC21 can also cause upregulation of ERKs in PC12 cells to promote the same consequences as activated Ras. Despite our uncertainties regarding the role of ERK activation in TC21 function, it is clear that the interaction of TC21 with Raf is not required.
Finally, we also observed that TC21 shared with Ras the ability to modulate the dierentiation of C2 skeletal myoblasts. Activated TC21, like Ras, can also block myoD-induced myoblast dierentiation of C3H10T1/2 mouse ®broblasts (Ramocki and Taparowsky, personal communication) . Although the signaling pathways that mediate this Ras eect in C2 cells has not been elucidated. Taparowsky and colleagues did ®nd that Raf-1 could also block the actions of myoD in C3H10T1/2 cells (Ramocki et al., 1997) . However, this action was not dependent on ERK function, since treatment with a MEK inhibitor did not block Ras-induced inhibition. Thus, they argued that a Raf/MEK/ERK pathway was not involved. They also observed that a Ras eector domain mutant, that was de®cient in Raf-1 binding, could still block MyoD-induced myogenesis. Their observations, together with our observations with TC21, demonstrate that Raf-1 is not an essential eector for Ras and TC21 inhibition of skeletal myogenesis.
In summary, we have found that TC21 and Ras share essentially identical biological activities in a variety of cell types. Although TC21 fails to activate Raf, it can interact with a number of other candidate eectors of Ras (e.g., RalGDS, AF6) and can activate other MAPK cascades that are activated by Ras. Thus, we suggest that TC21 may be viewed as a naturally occurring`eector domain mutant' of Ras and provides clear evidence that much of the biological functions of Ras may also not require Raf. However, TC21 transforming activity is qualitatively and quantitatively distinct from the Ras eector mutants (harboring 37G or 40C eector domain mutations) that are impaired in Raf binding and activation (White et al., 1995; Khosravi-Far et al., 1996) . Thus, TC21 may still activate a novel Raf-related kinase that can facilitate the same functions that Raf provides for Ras. We are in the process of screening for TC21-interacting proteins that may provide such a function.
Materials and methods

Molecular constructs
This pZIP-NeoSV(x)1 retrovirus eukaryotic cell expression vectors (Moloney LTR promoter; neo r ) encoding wild type H-Ras, TC21 and Rac1, constitutively activated H-Ras (12V), H-Ras(61L), K-Ras(12V), and TC21(72L), and dominant negative TC21(22A), TC21(24N) and Rac1(17N) have been described previously Graham et al., 1994 . pCGN-hyg mammalian expression vectors (CMV promoter, hygromycin-resistant) encoding hemagglutinin (HA) epitopetagged versions of wild type (WT) TC21, or constitutively activated TC21(72L) and H-Ras(61L) have been described previously (Graham et al., 1996) . Expression vectors encoding HA epitope-tagged ERK2 (provided by M Weber) and FLAG epitope-tagged JNK1 or p38 (provided by Michael Karin) have been described previously . Bacterial expression vectors encoding TC21, H-Ras and Raf-1 proteins have been described previously (Carboni et al., 1995; Drugan et al., 1996) .
Radioactive direct binding assay
Puri®cation of bacterially-expressed recombinant proteins have been described previously. The H-Ras(12V), TC21, and Raf-CRD (Raf-1 residues 134 ± 187) bacterial expression constructs were expressed in E. Coli as glutathione Stransferase (GST) fusion proteins and puri®ed by anity chromatography as described (Ghosh and Bell, 1994) . The Raf-CRD was further puri®ed from GST by cleaving a thrombin-speci®c site between the Raf-CRD fusion protein and GST. Recombinant H-Ras(WT) was also expressed and puri®ed from E. coli as described previously (Campbell-Burk and Carpenter, 1995) . H-Ras(WT), H-Ras(12V), and TC21 were labeled with a slowly hydrolyzable GTP analog (GMPPNP) (Miller et al., 1993) . RBS-1 (Raf-1 residues 51 ± 131) was expressed as a fusion protein with maltose-binding protein (MBP) and RBS-1-MBP was puri®ed by anity chromatography (Drugan et al., 1996) . 0.2 nM of g-32 P-GTP-labeled Ras(12V) or TC21 was incubated with 0.5 mM RBS-1 fused to MBP (or MBP alone) in 20 mM HEPES pH 7.4, 1 mM MgCl 2 , 1 mg/ml bovine serum albumin and 0.3% Triton-X-100 essentially as described elsewhere (Drugan et al., 1996) . The RBS-1-MBP complexed with Ras or TC21 was isolated by binding MBP to amylose-coated beads. The presence of radiolabeled Ras or TC21 was determined by scintillation counting. Assays were performed at least three times in duplicate.
Enzyme-linked immunosorbent assays (ELISA)
One hundred pmole of Raf-CRD protein, which have been cleaved from GST, was immobilized to each well of a polystyrene 96-well plate (Galson et al., 1993) . Following blocking with gelatin and normal sheep serum to obviate non-speci®c interactions as described previously (Brtva et al., 1995) , the Raf-CRD was exposed to 100 pmoles TC21-GMPPNP fused to GST, GST alone, or Ras(WT)-GMPPNP. The captured protein was labeled with an anti-GST monoclonal (1 : 500 dilution; Santa Cruz Biotech) or anti-H-Ras monoclonal (1 : 2000 dilution; Quality Biotech) antibody. Following incubation with a sheep anti-mouse IgG-alkaline phosphatase (AP) antibody (1 : 1000 dilution; Sigma), the interaction between the Raf-CRD and the protein of interest was detected by a colorimetric change following the addition of an AP substrate, p-nitrophenyl phosphate. After 30 min, the optical density was measured at 405 nm with a Biotech microtiter plate reader. All experiments were done at least three times in duplicate.
COS-7 transient expression MAPK assays
ERK, JNK and p38 kinase assays were performed as described previously by transient expression in COS-7 cells Clark et al., 1997b) . COS-7 cells were cultured in Dulbecco's modi®ed Eagle's medium (DMEM) supplemented with 10% fetal calf serum (Hyclone) and transfected using the lipofectamine reagent (Gibco ± BRL) as described by the manufacture. Cells were transfected with 1 mg of either pCGN-hyg (empty vector control), pCGN-H-ras(61L), pCGN-tc21(WT), or pCGNtc21(72L)pCGN-hyg, pCGN-H-ras(61L), and pCGNrac1(61L) along with 1 mg of plasmid DNAs encoding HA epitope-tagged ERK2, FLAG epitope-tagged JNK1 or FLAG epitope-tagged p38. Thirty-six hours after transfection, cells were then serum-starved in DMEM supplemented with 0.5% FBS for 12 ± 16 h. Cells were collected in 750 ml of lysis buer containing proteases and phosphatase inhibitors (Westwick and Brenner, 1995) . Protein concentration was determined using the BioRad Protein Assay with bovine serum albumen as a standard and 250 mg of lysate was used for immunoprecipitation. Epitope-tagged kinases were immunoprecipitated with either anti-HA (BabCo) or anti-FLAG (Kodak Eastman) antibodies and protein A/G agarose beads (Santa Cruz Biotech). Kinase assays were performed as described previously with myelin basic protein (MBP), glutathione-S-transferase (GST) conjugated c-Jun [GST-c-Jun(1 ± 79)] or ATF-2 [GST-ATF-2(1 ± 254)] as substrates for the ERK2, JNK1 and p38 kinase assays, respectively. Reactions were stopped with 26Laemmli sample buer and resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS ± PAGE). Proteins were transferred to Immobilon membranes (Millipore) and the membranes were then exposed to ®lm. Incorporated radioactivity was quantitated on a Phosphorimager (Molecular Dynamics). For standardization of transfection eciency, 25 mg of total cell protein was analysed by Western blot analysis as described previously Clark et al., 1997b) .
Cell culture and transformation assays NIH3T3 cells were cultured in DMEM supplemented with 10% calf serum. DNA transfections were performed as previously described using the calcium phosphate precipitation technique (Clark et al., 1995) . To determine if TC21 transforming activity required the function of Rac1, NIH3T3 cells were transfected with 10 ng of pZIPtc21(23V), either alone, or together with 1, 2 or 5 mg of plasmid DNA encoding Rac(WT) or Rac(17N). Transformed foci were quantitated after 14 ± 16 days.
Rat intestinal epithelial (RIE-1) cells were grown in DMEM supplemented with 5% fetal calf serum. To establish cell lines that stably expressed activated Ras or TC21 proteins, RIE-1 cells were transfected with 1 mg of pZIP plasmid cDNAs encoding mutant TC21(72C) or H-Ras(12V) using the lipofectamine method as described previously (Oldham et al., 1996) . After 48 h, cells were grown in selection growth medium that contained 400 mg per ml G418 (Geneticin, Gibco/BRL) and multiple, G418-resistant colonies (4100) were pooled together to establish cell lines stably expressing these mutant proteins.
PC12 rat pheochromocytoma cells (provided by B Hempstead) were grown in DMEM supplemented with 10% calf serum and 5% horse serum. DNA transfections were done by the Lipofectamine method. Cells were plated on collagen-coated dishes (Biomedical Technologies), then transfected the following day with 10 mg of pZIP plasmid DNAs encoding wild type and activated TC21 or Ras proteins. After an additional 24 h, the cultures were then maintained in growth medium supplemented with 400 mg per ml G418 to select for cells stably-transfected with the indicated expression vector.
C2 myoblast cells (provided by Y Xhong) were grown in DMEM supplemented with 15% fetal calf serum. One mg of pZIP plasmid DNA encoding wild type or activated TC21 or Ras proteins, or dominant negative TC21 proteins, were transfected into C2 cells using calcium phosphate precipitation (Buss et al., 1989) . After 24 h, cells were grown in selection growth medium supplemented with 400 mg per ml G418 to establish mass populations of cells that stably expressed wild type or mutant TC21 or Ras proteins. To induce dierentiation, C2 cells stably transfected with the empty vector control, or expressing exogenously-introduced Ras or TC21 protein expression constructs were grown to 70% con¯uency, then fed with DMEM containing 2% horse serum (Donor) and 10 mg/ml insulin (Gibco/BRL). After approximately 1 week, cells were scored for any acquired dierentiation characteristics.
All stably transfected cells were assayed for protein expression from the exogenously-introduced constructs. Lysates were generated from con¯uent cultures and the proteins resolved by SDS ± PAGE and then transferred onto nitrocellulose. Proteins were detected in Western blot analysis using either 1638 (anti-TC21 polyclonal) or 142 (anti-Ras monoclonal) antibodies. Antibody binding was detected by enhanced chemiluminescence (Amersham) (data not shown).
